Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Euro Surveill ; 26(30)2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34328076

RESUMO

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully vaccinated. Transmission occurred despite the use of personal protective equipment by the HCW, as advised in national guidelines, and a high two-dose COVID-19 vaccination coverage among permanent staff members in the COVID-19 cohort ward.


Assuntos
COVID-19 , SARS-CoV-2 , Vacinas contra COVID-19 , Surtos de Doenças , Finlândia/epidemiologia , Pessoal de Saúde , Hospitais , Humanos , Atenção Secundária à Saúde
2.
J Antimicrob Chemother ; 76(10): 2697-2701, 2021 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-34164687

RESUMO

OBJECTIVES: Carbapenemase-producing Enterobacterales (CPE) have spread widely into health care facilities (HCF) but clusters caused by carbapenemase-producing (CP) Citrobacter freundii have been uncommon until recent years. Here we describe CP C. freundii clusters detected in Finland during 2016-20. METHODS: As a part of the national CPE surveillance, clinical microbiology laboratories send potential CP C. freundii isolates to the reference laboratory for confirmation and further characterization. Whole genome sequencing (WGS) with Illumina MiSeq sequencer was used to detect clusters. Resistance genes and STs were analysed using SRST2 and typing with core genome (cg) MLST. A case was defined as a patient with a CP C. freundii isolate belonging to one of the detected clusters. RESULTS: We detected three CP C. freundii clusters: cluster 1 included 16 cases in five HCFs during 2016-20, cluster 2 had two cases in two HCFs during 2018-19 and cluster 3 had two cases in one HCF in 2020. The isolates (11 clinical and 5 screening) in cluster 1 had KPC-2 carbapenemase and were sequence type (ST)18. Cluster 2 (2 clinical isolates) had OXA-181/GES-5 carbapenemases and were ST604 and cluster 3 (two screening isolates) had KPC-3 carbapenemase and were ST116. None of the cases had a history of recent travel abroad. CONCLUSIONS: CP C. freundii also causes outbreaks and can be a reservoir of carbapenemase genes. The long intervals between successive cases, mostly found in clinical specimens in two clusters, suggest that besides unknown carriers, environmental contamination may play a role in transmission.


Assuntos
Citrobacter freundii , Infecções por Enterobacteriaceae , Proteínas de Bactérias/genética , Citrobacter freundii/genética , Infecções por Enterobacteriaceae/epidemiologia , Finlândia/epidemiologia , Humanos , Tipagem de Sequências Multilocus , beta-Lactamases/genética
3.
Infect Dis (Lond) ; 53(9): 684-690, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33974504

RESUMO

BACKGROUND: Cryptococcosis is one of the major causes of mortality among HIV patients worldwide. Though most often associated with late stage HIV infection/AIDS, a significant number of cases occur in other immunocompromised patients such as solid organ transplant recipients and patients with hematological malignancies. Immunocompromised patients are a heterogeneous group and their number increases constantly. Since little is known about the incidence and the clinical features of cryptococcosis in Northern Europe, our aim was to investigate the clinical characteristics of cryptococcosis patients in Finland. METHODS: We retrospectively reviewed the laboratory confirmed cryptococcosis cases in Finland during 2004-2018. Only those who were treated for cryptococcosis were included in the study. Initial laboratory findings and medical records were also collected. RESULTS: A total of 22 patients with cryptococcosis were included in our study. The annual incidence of cryptococcosis was 0.03 cases per 100,000 population. Ten patients were HIV-positive and 12 out of 22 were HIV-negative. Hematological malignancy was the most common underlying condition among HIV-negative patients. CONCLUSIONS: To our knowledge, this is the first study of the clinical presentation and incidence of cryptococcosis in Finland. We demonstrate that invasive cryptococcal infection occurs not only in HIV/AIDS patients or otherwise immunocompromised patients but also in immunocompetent individuals. Even though cryptococcosis is extremely rare in Finland, its recognition is important since the prognosis depends on rapid diagnostics and early antifungal therapy.


Assuntos
Criptococose , Cryptococcus neoformans , Infecções por HIV , Antifúngicos/uso terapêutico , Criptococose/epidemiologia , Finlândia/epidemiologia , Infecções por HIV/complicações , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Humanos , Incidência , Estudos Retrospectivos
4.
Duodecim ; 129(15): 1586-9, 2013.
Artigo em Finlandês | MEDLINE | ID: mdl-24163977

RESUMO

Osteomyelitis is an infection of bone, which most frequently is found in weight-bearing bones of lower extremities. Only 4% of acute osteomyelitis cases have been found in the pubic bones in Finland. These cases of the pubic bones are usually related to gynecological or urological procedures or trauma. Osteitis, which is much more common than osteomyelitis, is a differential diagnosis for pregnant or postpartum women. These two diseases are difficult to distinguish based on the symptoms, even if it is important because osteomyelitis needs to be cured with antibiotics but to cure osteomyelitis NSAIDs are enough. The diagnosis of osteomyelitis is based on clinical examination, radiological imaging and laboratory tests.


Assuntos
Osteomielite/diagnóstico , Complicações Infecciosas na Gravidez/diagnóstico , Adulto , Antibacterianos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Diagnóstico Diferencial , Diagnóstico por Imagem , Feminino , Finlândia , Humanos , Osteíte/diagnóstico , Osteíte/tratamento farmacológico , Osteomielite/tratamento farmacológico , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico
5.
J Infect Dis ; 189(5): 766-74, 2004 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-14976592

RESUMO

BACKGROUND: The vehicles and sources of Yersinia pseudotuberculosis infection are unknown. In Finland, clinical microbiology laboratories routinely report Y. pseudotuberculosis isolations and submit isolates for serotype analysis. In October 1998, the number of serotype O:3 infections increased markedly. METHODS: Case patients with culture-confirmed Y. pseudotuberculosis O:3 infection were identified by use of laboratory-based surveillance. We conducted a population-based case-control study. Healthy community control subjects were matched by age, sex, and postal code. Isolates were subtyped by pulsed-field gel electrophoresis (PFGE). RESULTS: Nationwide, 47 case patients were identified (age range, 2-77 years; median, 19 years). One patient with bacteremia died; 5 underwent appendectomies. We enrolled 38 case patients and 76 control subjects in the case-control study. Seventy-one percent of case patients and 42% of control subjects reported having eaten iceberg lettuce (matched odds ratio, 3.8; 95% confidence interval, 1.3-9.4); a dose-response relationship was found for increasing frequency of consumption. Of the 27 isolates obtained from case patients and tested in the analysis, all had indistinguishable PFGE patterns. Four lunch cafeterias that had served iceberg lettuce were associated with clusters of case patients. The lettuce was traced back to originating farms. CONCLUSIONS: Iceberg lettuce was implicated as the vehicle of a widespread foodborne Y. pseudotuberculosis outbreak. Ongoing laboratory-based surveillance and serotype analysis were essential in the rapid detection of infection. Cases of yersiniosis, which appear to be sporadic, may be part of unrecognized outbreaks caused by contaminated fresh produce.


Assuntos
Surtos de Doenças , Microbiologia de Alimentos , Infecções por Yersinia pseudotuberculosis/epidemiologia , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Finlândia/epidemiologia , Hospitalização/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Yersinia pseudotuberculosis/transmissão
7.
Pharmacol Biochem Behav ; 73(3): 697-702, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12151046

RESUMO

The purpose of the present study was to investigate the effects of repeated morphine and cocaine treatments on rotational behaviour in alcohol-preferring AA (Alko Alcohol) and alcohol-avoiding ANA (Alko Non-Alcohol) rats after unilateral 6-hydroxydopamine lesions of the ascending dopamine pathways. We administered saline, morphine (1 or 3 mg/kg) or cocaine (10 mg/kg) once daily for 4 days with an additional challenge 8 days after the repeated drug treatment. Ipsilateral rotations of the animals were monitored after each drug treatment. Both morphine (3 mg/kg but not 1 mg/kg) and cocaine induced more rotational behaviour in AA than in ANA rats over the 4-day drug treatment period. On Day 12, a challenge with 3 mg/kg morphine or cocaine induced significantly more rotations in the AA rats pretreated with morphine or cocaine when compared to saline-treated AA rats exposed to these drugs for the first time. This finding indicates that sensitization to the effects of morphine and cocaine occurs in the AA rats, while no clear sensitization was seen in the ANA rats. Collectively, these results suggest that morphine and cocaine activate the cerebral dopamine pathways to a greater extent in AA than in ANA rats.


Assuntos
Consumo de Bebidas Alcoólicas/genética , Consumo de Bebidas Alcoólicas/psicologia , Cocaína/farmacologia , Morfina/farmacologia , Entorpecentes/farmacologia , Comportamento Estereotipado/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Masculino , Oxidopamina , Ratos , Rotação , Técnicas Estereotáxicas , Simpatectomia Química , Simpatolíticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...